ACLY and prostate carcinoma: For example, c-Myc maintains the glycolytic activity (33) and increases the expression of key fatty acid synthesis genes, such as ATP citrate lyase, acetyl-CoA carboxylase alpha, and fatty acid synthase (34), thus promoting prostate cancer progression (35).